Literature DB >> 15460856

Consumption of drugs for sea lice infestations in Norwegian fish farms: methods for assessment of treatment patterns and treatment rate.

K Grave1, T E Horsberg, B T Lunestad, I Litleskare.   

Abstract

Sea lice are a major problem in Norwegian fish farms; however, data on drug treatment patterns or treatment rates of sea lice infestations are not available. Such data are important for analysing resistance patterns against drugs used for such infestations. The main objective of the present study was to develop a method to estimate the treatment patterns and treatment rates for drugs used in the treatment against sea lice (Lepeophtheirus salmonis and Caligus elongatus) in farm salmonids by means of national sales statistics. Annual sales figures, as weight of active substances, were obtained from the drug wholesalers and the feed mills. The weight of active drug substances is not useful as a unit of measurement of drug use in an epidemiological context because it does not correct for dosage differences and number of repeat treatments. To correct for these factors, we introduced approved daily dose (ADD(farm fish)) and treatment course-doses(farm fish) kg(-1) live-weight fish. To express the drug treatment patterns, the biomass (in weight) of farm salmonids treated with 1 course of a drug were estimated. When measured as kg active substance, the quantities of drugs for the treatment of sea lice infestations declined by 98% during the study period (1989 to 2002) but this figure increased 5-fold when it was corrected for differences in dosage. To correct for amounts of farm salmonids liable to require treatment we estimated the annual treatment rate, defined as the number of treatments for sea lice infestations per biomass slaughtered Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss. The annual treatment rate increased gradually during the study period; however, it varied considerably (range 0.45 to 1.34, mean 0.90). Before 1995, organophosphates were the most frequently used drugs against sea lice; since then pyrethroids have become the dominating drug group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460856     DOI: 10.3354/dao060123

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  5 in total

1.  Mechanism behind Resistance against the Organophosphate Azamethiphos in Salmon Lice (Lepeophtheirus salmonis).

Authors:  Kiranpreet Kaur; Kari Olli Helgesen; Marit Jørgensen Bakke; Tor Einar Horsberg
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 2.  Salmon lice--impact on wild salmonids and salmon aquaculture.

Authors:  O Torrissen; S Jones; F Asche; A Guttormsen; O T Skilbrei; F Nilsen; T E Horsberg; D Jackson
Journal:  J Fish Dis       Date:  2013-01-13       Impact factor: 2.767

3.  Phe362Tyr in AChE: A Major Factor Responsible for Azamethiphos Resistance in Lepeophtheirus salmonis in Norway.

Authors:  Kiranpreet Kaur; Peder Andreas Jansen; Vidar Teis Aspehaug; Tor Einar Horsberg
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

4.  Candidate genes for monitoring hydrogen peroxide resistance in the salmon louse, Lepeophtheirus salmonis.

Authors:  Celia Agusti-Ridaura; Marit Jørgensen Bakke; Kari Olli Helgesen; Arvind Y M Sundaram; Sigrid Jørgensen Bakke; Kiranpreet Kaur; Tor Einar Horsberg
Journal:  Parasit Vectors       Date:  2020-07-10       Impact factor: 3.876

5.  Trends in de-lousing of Norwegian farmed salmon from 2000-2019-Consumption of medicines, salmon louse resistance and non-medicinal control methods.

Authors:  Elena Myhre Jensen; Tor Einar Horsberg; Sigmund Sevatdal; Kari Olli Helgesen
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.